Lorico A - Search Results

1

Changes in chemosensitivity of K 562 leukemia cells after induction of erythroid differentiation by hemin.

Toffoli G, Lorico A, Boiocchi M. Toffoli G, et al. Among authors: lorico a. Tumori. 1988 Feb 29;74(1):11-7. doi: 10.1177/030089168807400103. Tumori. 1988. PMID: 3162623

2

Effect of hemin-induced differentiation on chemosensitivity of K 562 leukemia cells.

Tofeoli G, Lorico A, Boiocchi M. Tofeoli G, et al. Among authors: lorico a. J Chemother. 1989 Jul;1(4 Suppl):1157-8. J Chemother. 1989. PMID: 16312814 No abstract available.

3

Increase in topoisomerase-II-mediated DNA breaks and cytotoxicity of VP16 in human U937 lymphoma cells pretreated with low doses of methotrexate.

Lorico A, Boiocchi M, Rappa G, Sen S, Erba E, D'Incalci M. Lorico A, et al. Int J Cancer. 1990 Jan 15;45(1):156-62. doi: 10.1002/ijc.2910450128. Int J Cancer. 1990. PMID: 2153635

4

Increase in etoposide-induced topoisomerase II-mediated DNA breaks after cell synchronization induced by low doses of methotrexate.

Lorico A, Rappa G, Boiocchi M, Anzanello F, D'Incalci M. Lorico A, et al. Biochem Pharmacol. 1988 May 1;37(9):1883-4. doi: 10.1016/0006-2952(88)90494-7. Biochem Pharmacol. 1988. PMID: 2837248 No abstract available.

5

Accumulation of DNA strand breaks in cells exposed to methotrexate or N10-propargyl-5,8-dideazafolic acid.

Lorico A, Toffoli G, Boiocchi M, Erba E, Broggini M, Rappa G, D'Incalci M. Lorico A, et al. Cancer Res. 1988 Apr 15;48(8):2036-41. Cancer Res. 1988. PMID: 3349474

6

Early DNA damage induced in cells exposed to N10-propargyl 5,8-dideazafolic acid (CB 3717) or methotrexate.

Lorico A, Toffoli G, Boiocchi M, Erba E, Broggini M, Rappa G, D'Incalci M. Lorico A, et al. Biochem Pharmacol. 1988 May 1;37(9):1875-6. doi: 10.1016/0006-2952(88)90490-x. Biochem Pharmacol. 1988. PMID: 3377859 No abstract available.

7

Induction of the differentiation of WEHI-3B D+ monomyelocytic leukemia cells by inhibitors of topoisomerase II.

Rappa G, Lorico A, Sartorelli AC. Rappa G, et al. Among authors: lorico a. Cancer Res. 1990 Oct 15;50(20):6723-30. Cancer Res. 1990. PMID: 2170008

8

Development and characterization of a WEHI-3B D+ monomyelocytic leukemia cell line resistant to novobiocin and cross-resistant to other topoisomerase II-targeted drugs.

Rappa G, Lorico A, Sartorelli AC. Rappa G, et al. Among authors: lorico a. Cancer Res. 1992 May 15;52(10):2782-90. Cancer Res. 1992. PMID: 1316227

9

Potentiation of etoposide cytotoxicity against a human ovarian cancer cell line by pretreatment with non-toxic concentrations of methotrexate or aphidicolin.

Erba E, Sen S, Lorico A, D'Incalci M. Erba E, et al. Among authors: lorico a. Eur J Cancer. 1992;28(1):66-71. doi: 10.1016/0959-8049(92)90387-h. Eur J Cancer. 1992. PMID: 1314631

10

Mitozolomide activity on human cancer cells in vitro.

Erba E, Pepe S, Ubezio P, Lorico A, Morasca L, Mangioni C, Landoni F, D'Incalci M. Erba E, et al. Among authors: lorico a. Br J Cancer. 1986 Dec;54(6):925-32. doi: 10.1038/bjc.1986.263. Br J Cancer. 1986. PMID: 3801288 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

91 results

Search Page

Filters